|
|
|
|
| LEADER |
02382nmm a2200349 u 4500 |
| 001 |
EB000636653 |
| 003 |
EBX01000000000000000489735 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783034879309
|
| 100 |
1 |
|
|a Guglietta, Antonio
|e [editor]
|
| 245 |
0 |
0 |
|a Pharmacotherapy of Gastrointestinal Inflammation
|h Elektronische Ressource
|c edited by Antonio Guglietta
|
| 250 |
|
|
|a 1st ed. 2004
|
| 260 |
|
|
|a Basel
|b Birkhäuser
|c 2004, 2004
|
| 300 |
|
|
|a X, 146 p
|b online resource
|
| 505 |
0 |
|
|a List of contributors -- Preface -- Pharmacotherapy of Helicobacter pylori-associated gastritis -- Pharmacotherapy of inflammatory bowel disease: novel therapeutic approaches -- Current and future therapy of chronic hepatitis -- Treatment and prevention of antibiotic associated colitis -- Nitric oxide-donating aspirins spare the gastrointestinal (GI) system and improve the treatment of inflammation related GI and cardiovascular pathologies -- Oral tolerance for treatment of GI inflammation
|
| 653 |
|
|
|a Cell Biology
|
| 653 |
|
|
|a Proctology
|
| 653 |
|
|
|a Cytology
|
| 653 |
|
|
|a Immunology
|
| 653 |
|
|
|a Gastroenterology
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Medical Microbiology
|
| 653 |
|
|
|a Medical microbiology
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 490 |
0 |
|
|a Progress in Inflammation Research
|
| 028 |
5 |
0 |
|a 10.1007/978-3-0348-7930-9
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-0348-7930-9?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 615
|
| 520 |
|
|
|a In recent years, the area of pharmacotherapy of GI inflammation has witnessed important progress, with new drugs and therapeutic approaches being introduced. The volume reviews the pharmacotherapy of selected gastrointestinal inflammatory conditions chosen on the basis of their clinical importance and/or the areas where important and exciting progress has been made recently. Besides discussing current pharmacotherapy to treat the most important GI inflammation conditions, the book also indicates possible future therapeutic avenues likely to become available in a few years. The book is of interest to various sectors of the scientific community ranging from clinicians to pharmacologists and from biochemists to microbiologists, who will find it a useful tool for their clinical practice and research activity
|